About Audrey Shearer

Owner/founder of Spiral, a software development company based in Wellington, New Zealand. Beekeeper, gardener, motorcyclist, vegetarian, I abhor cruelty to animals.

Win an iPad at the ANZICS Sydney Winter Research Forum

ANZICS 2018 Winter Research Forum Spiral is running the ANZICS Winter Forum iPad competition again! The prize of a brand new, 32Gb iPad which will be presented on Tuesday the 28th of August immediately prior to morning tea. This is the NEW iPad that supports Apple Pencil! Here's what we want you to [...]

By | August 12th, 2018|Uncategorized|0 Comments

ICU-ROX 1,000 patients enrolled

ICU-ROX has reached it's target of 1,000 patients enrolled which means congratulations, not just to Paul Young and Di Mackle, who lead the teams but to each and every person involved. From the patients, to the clinicians, to the research coordinators to the project management team - it's a pleasure to work with people, like you, who [...]

By | May 29th, 2018|Study Success|Comments Off on ICU-ROX 1,000 patients enrolled

Reflecting on User Testing

It seems the last few weeks have been an endless round of user testing. REMAP-CAP and TTM2 and TAME - all three trials have been through user testing at the same time. To be honest it's been a testing month of user testing! User testing takes patience and attention to detail. It's time consuming and [...]

By | May 21st, 2018|Spinnaker, Usability|0 Comments

What happens when you ask for a change to Spinnaker

Devops deployment So you have found something in your study that needs to change. Heres a small insight into what we do when you ask for a change. It could be that something in your CRF has changed, you have found a better way to do something or maybe something in Spinnaker [...]

By | February 15th, 2018|Uncategorized|0 Comments

Past and Future choices

Have you made any New Year resolutions? It’s that time of year when many of us wonder about the fresh new year where we get a chance to begin again, to set new goals and make new choices. Perhaps you looked back at 2017.  For us, 2017 was our biggest year yet with 11 trials [...]

By | January 4th, 2018|Uncategorized|Comments Off on Past and Future choices

Merry Xmas

Merry Xmas to everyone using Spinnaker.    During the year you randomised patients, published results and initiated new research. 2017 is our biggest year yet with 11 trials on our books. 2017 highlights include: over 5,200 patients were randomised this year using Spinnaker TARGET(Monash) and NovelSTART(MRINZ) completed enrolments  Bryn Gilbertson joined the team to manage [...]

By | December 12th, 2017|Uncategorized|Comments Off on Merry Xmas

O TARGET

TARGET 4000 Enrolment completed this week! What a phenomenal achievement from everyone involved in TARGET. Congratulations to you all because in just 18 months 46 intensive care units in Australia and New Zealand enrolled 4,000 patients. That's an average of 7.5 patients a day!   The busiest day was the 4th of August [...]

By | November 16th, 2017|Study Success|Comments Off on O TARGET

We layered up our Firewall in the fight against cyber hacking

Firewall diagram There has been a firewall protecting our clinical trial servers (and your data) ever since we put our first project in “the cloud” in 2013. In the past 5 years we have had no incidents but in our striving for excellence we have gone one step further and added another layer [...]

By | November 1st, 2017|Security|0 Comments

TARGET Case Study Published

As the TARGET Trial races towards the successful enrolment of its 4,000 patients, we are pleased to publish a case study of our involvement in the project. TARGET involves 46 ICU's in both New Zealand and Australia. The trial commenced in 2016, it has been recruiting at extremely high rates. Enrolments will be completed early, certainly [...]

By | October 30th, 2017|Case studies|0 Comments

Plus has started enrolments

Time to celebrate as the PLUS Trial has begun taking enrolments.  For the team at The George Institute and us here at Spiral, it’s a major milestone. Enrolments mean the completion of the development stage and advancement towards the target of enrolling 8,800 patients.  Enrolments also mean the first shipments of study treatment have been [...]

By | October 12th, 2017|Uncategorized|0 Comments